FDA Inspection 1255722 — University Of Texas MD Anderson Cancer Center

University Of Texas MD Anderson Cancer Center — FEI 1640006

The FDA completed an inspection of University Of Texas MD Anderson Cancer Center on Nov 18, 2024 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.